International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
ICICSF-2025
IC-AIRCM-T³
Conferences Published ↓
SVGASCA (2025)
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 6
November-December 2025
Indexing Partners
Impact of the New Labour Codes on the Pharmaceutical Industry in India
| Author(s) | Mr. Raushan NA |
|---|---|
| Country | India |
| Abstract | India’s pharmaceutical sector is one of the country’s most strategically important industries, contributing significantly to employment, healthcare delivery and global drug supply chains. The implementation of four consolidated labour codes—the Code on Wages (2019), Industrial Relations Code (2020), Code on Social Security (2020) and the Occupational Safety, Health and Working Conditions Code (2020)—in November 2025 marks a major legislative shift intended to simplify compliance requirements, enhance worker protection and modernize labour governance. This paper provides a detailed and comprehensive examination of how these reforms affect the pharmaceutical industry. The analysis draws upon secondary sources including government notifications, legal commentaries, expert reports and industry assessments to evaluate how wage restructuring, contract labour regulation, occupational safety standards and industrial relations are reshaped by the new legal framework. The findings indicate that while the reforms impose notable short-term compliance and financial burdens, they offer long-term benefits by strengthening worker welfare, reducing regulatory fragmentation, and improving the predictability of labour practices. The study concludes by offering policy and managerial recommendations aimed at enabling pharmaceutical companies to transition smoothly into the new labour framework while maintaining operational efficiency and regulatory compliance. |
| Keywords | Labour Codes, Pharmaceutical Industry, Wage Restructuring, Contract Labour, Occupational Safety, Industrial Relations, India |
| Published In | Volume 7, Issue 6, November-December 2025 |
| Published On | 2025-11-27 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i06.61880 |
| Short DOI | https://doi.org/hbdsrh |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.